Status:
COMPLETED
Evaluation of Brain Damage Due to Coronary Angioplasty in Percutaneous Intervention Patients
Lead Sponsor:
Ondokuz Mayıs University
Conditions:
Silent Stroke
Coronary Disease
Eligibility:
All Genders
18-80 years
Brief Summary
This study examines the formation mechanism and patient-related factors of silent cerebral infarcts, whose importance has become increasingly recognized in patients undergoing percutaneous coronary in...
Detailed Description
This study was produced from the assistant's thesis and was previously accepted as a poster at EuroPCR 2020. We recently completed the full-length article. This thesis study was supported by Ondokuzm...
Eligibility Criteria
Inclusion
- CTO and Non-CTO patients undergoing percutaneous coronary intervention
Exclusion
- baseline NSE elevation
- acute coronary syndromes or cardiac surgery within 4 weeks
- patients with a cerebrovascular accident
- intracranial hemorrhage
- and head trauma
- central nervous system tumor
- degenerative central nervous system disorders and neuroendocrine tumors
Key Trial Info
Start Date :
January 18 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 25 2020
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04734587
Start Date
January 18 2019
End Date
March 25 2020
Last Update
October 6 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ondokuzmayis University
Samsun, Turkey (Türkiye)